Header image

Opening Ceremony and Session A: Epidemiology and Public Health

Wednesday, September 6, 2017
8:30 AM - 10:50 AM
Manhattan Ballroom

Speaker

Professor Of Medicine And Psychiatry Alain Litwin
Professor Of Medicine And Psychiatry
Albert Einstein College Of Medicine And Montefiore Medical Center

Welcome to the Conference

8:30 AM - 8:40 AM

Speaker Presentation

Video Presentation

Biography

Agenda Item Image
Dr Sarah Larney
Senior Research Fellow
National Drug And Alcohol Research Centre, University of New South Wales , Sydney, Australia

The Global Epidemiology Injecting Drug Use, HIV, Viral Hepatitis And Harm Reduction Services Among People Who Inject Drugs

8:40 AM - 9:05 AM

Speaker Presentation

Video Presentation

Biography

Sarah Larney is a Senior Research Fellow at the National Drug and Alcohol Research Centre, University of New South Wales. Her work focuses on injecting drug use and related harms, including infectious diseases and intersections with the criminal justice system.
Agenda Item Image
Doctor Mark Tyndall
Executive Director
British Columbia Centre For Disease Control

The Opioid Crisis In North America: A Call For Better Access To Health Care For People Who Inject Drugs

9:05 AM - 9:30 AM

Speaker Presentation

Video Presentation

Biography

Dr. Mark Tyndall is the Executive Medical Director of the BC Centre for Disease Control and Professor at the UBC School of Population and Public Health. He is an infectious diseases specialist with a focus on urban health and addiction. His career awards include the Michael Smith Foundation for Health Research Senior Scholar Award and the Ontario HIV Treatment Network Applied Research Chair. He is an author on over 250 peer-reviewed publications, with a focus on HIV and Hepatitis C care and prevention, harm reduction, and public health implementation research. He was co-lead investigator on the evaluation of Insite, North America’s first supervised injection site. Dr. Tyndall is a strong advocate and leader for public health in Canada and has fostered a number of community-based collaborations that have led to health policy changes.
Dr. Jennifer Havens
Professor
University Of Kentucky

Prescription Opioid Use, Injecting Drug Use And HCV In Rural And Suburban Settings

9:30 AM - 9:55 AM

Speaker Presentation

Video Presentation

Biography

Jennifer Havens, PhD, MPH trained in infectious diseases epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is currently an Associate Professor in the Center on Drug and Alcohol Research and Department of Behavioral Science at the University of Kentucky College of Medicine. Dr. Havens studies the epidemiology of prescription opioid abuse in rural Appalachia and has a keen interest in the infectious outcomes (HIV/hepatitis C) of injection drug use in this population. She has received three R01 awards from NIH/NIDA to research the rural opioid abuse/infectious disease syndemic.
Dr. Thomas Stopka
Assistant Professor
Tufts University School Of Medicine

Identifying, Entering, And Characterizing HCV Hotspot Clusters: A Mixed Methods Approach

9:55 AM - 10:10 AM

Abstract

Speaker Presentation

Video Presentation

Biography

Thomas J. Stopka, PhD, MHS, is an Assistant Professor with the Department of Public Health and Community Medicine at the Tufts University School of Medicine. Dr. Stopka’s research interests are in infectious disease epidemiology, substance use and misuse, and spatial epidemiology. Much of his health disparities research has focused on the clustering of disease outcomes, and access to public health and disease prevention services. Dr. Stopka has used mixed methods research to contribute to studies in the U.S. and globally.
Agenda Item Image
Professor Matt Hickman
Professor
University of Bristol

Needle Syringe Programmes And Opioid Substitution Therapy For Prevention HCV Transmission Among People Who Inject Drugs: Cochrane Systematic Review

10:10 AM - 10:25 AM

Abstract

Speaker Presentation

Video Presentation

Biography

Prof Hickman is member of INHSU
Agenda Item Image
Prof Jason Grebely
Professor
UNSW/Kirby Institute

INHSU Special Issue in the International Journal of Drug Policy: Elimination of Hepatitis C Virus Infection among PWID: The Beginning of a New Era of Interferon-Free DAA Therapy

10:25 AM - 10:30 AM

Video Presentation

Biography

loading